YIDU TECH (02158) has been buying back shares for 4 consecutive days, accelerating the empowerment of grassroots medical institutions with its "AI assistant for general medical diagnosis and treatment".

On January 28th, YIDU TECH (02158) once again issued a stock buyback announcement, announcing the repurchase of 121,800 shares at a price of approximately HK$6 per share on the same day, costing approximately HK$730,000. With this, the company has implemented buyback operations for 4 consecutive trading days, repurchasing a total of approximately 830,000 shares, cumulatively costing nearly HK$5 million, in order to continue to convey confidence to the market through sustained actions. While actively releasing signals on the capital side, YIDU TECH has also made significant progress in business expansion and product implementation. On the 28th, it was announced that the number of participants in the company's main operation, "Beijing Inclusive Health Protection" for the year 2026, has surpassed 4.5 million. As the enterprise that has been the main operator of this project for 5 consecutive years, YIDU TECH, with its professional operational services and technological empowerment, continues to support the construction of a multi-level medical security system in the capital, demonstrating its business strength and market recognition. Furthermore, the company has also made new breakthroughs in the implementation of large-scale medical scenarios. The "General Medicine Diagnosis and Treatment AI Assistant" jointly developed by the Department of General Medicine of the First Affiliated Hospital of Chongqing Medical University and YIDU TECH has been in operation since its trial launch in May 2025. It has been deployed in over 20 grassroots medical institutions in Chongqing, covering multiple districts and counties, serving more than 1,000 medical personnel, and gradually forming a replicable and scalable solution for primary healthcare smart medical solutions.